- Rescinnamine
-
Rescinnamine Systematic (IUPAC) name methyl (3β,16β,17α,18β,20α)-11,17-dimethoxy-18-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}yohimban-16-carboxylate Clinical data Pregnancy cat. ? Legal status ℞ Prescription only Routes oral Identifiers CAS number 24815-24-5 ATC code C02AA01 PubChem CID 5280954 DrugBank APRD00112 ChemSpider 4444446 UNII Q6W1F7DJ2D KEGG D00198 ChEBI CHEBI:28572 ChEMBL CHEMBL1668 Synonyms methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate Chemical data Formula C35H42N2O9 Mol. mass 634.716 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
It is an alkaloid obtained from Rauwolfia serpentina[1] and other species of Rauwolfia.
Brand names
Moderil, Cinnasil, Anaprel
References
- ^ FIFE R, MACLAURIN JC, WRIGHT JH (December 1960). "Rescinnamine in treatment of hypertension in hospital clinic and in general practice". British medical journal 2 (5216): 1848–50. doi:10.1136/bmj.2.5216.1848. PMC 2098607. PMID 13699407. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2098607.
Sympatholytic (and closely related) antihypertensives (C02) Sympatholytics
(antagonize α-adrenergic
vasoconstriction)CentralAdrenergic release inhibitorsBethanidine • Bretylium • Debrisoquine • Guanadrel • Guanazodine • Guanethidine • Guanoclor • Guanoxan • Guanazodine • Guanoxabenz • GuanoxanImidazoline receptor agonistMecamylamine • Pentolinium • TrimethaphanPeripheralIndirectRescinnamine • ReserpineTyrosine hydroxylase inhibitorDirectNon-selective α blockerOther antagonists Endothelin antagonist (for PH)Categories:- ACE inhibitors
- Antihypertensive agents
- Phenol ethers
- Cinnamates
- Antihypertensive agent stubs
Wikimedia Foundation. 2010.